Telbivudine                            
                            
                                A thymidine derivative and antiviral agent that inhibits DNA synthesis by HEPATITIS B VIRUS and is used for the treatment of CHRONIC HEPATITIS B.
                                
                            
                                推出的年份: 2019(2004)                            
                                                                                        
                            
                            
                                                                树号: D03.383.742.680.705.888, D13.570.230.855.888, D13.570.685.705.888                            
                            
                                MeSH 单一 ID: D000077712                            
                                                                                        
                                    进入的组:
                                    
                                                                                    - 1-(2-Deoxy-beta-L-erythropentafuranosyl)-5-methyl-2,4(1H,3H)-pyrimidinedione
 
                                                                                    - beta-L-2'-Deoxythymidine
 
                                                                                    - beta L 2' Deoxythymidine
 
                                                                                    - Telbivudin
 
                                                                                    - Tyzeka
 
                                                                            
                                 
                            
                                                        
                                                                                                                        
                                                                        
                                                            
                            
                            
                         
                                                                                                
留言 (0)